Anti-DFS70 as a Marker of Non-Systemic Autoimmune Events (Primary Biliary Cholangitis) in Systemic Lupus Erythematosus

    Yasjudan Rastrama Putra, Deshinta Putri Mulya, Fahmi Indrarti
    Studysummary This case study highlights that primary biliary cholangitis in a patient with systemic lupus erythematosus can respond well to ursodeoxycholic acid therapy, and anti-DFS70 findings may require further evaluation for other nonsystemic autoimmune conditions.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →